NRT-YHD-001

N/A

Report date: 2025/07/14 16:28:47

NME

Base Information

Drug NameNRT-YHD-001

Drug Alias NameNRT-YHD-001NRT-YHD_001

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionThrombospondin 1 modulatorsMacrophages stimulants

TargetsThrombospondin 1

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNEORNAT Inc

China Registration ClassN/A

Develop Information

Active CompaniesNEORNAT Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A